Cary Street Partners Investment Advisory’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
N
Cary Street Partners Investment Advisory's BSX Position: Q2 2026 in Review
Cary Street Partners Investment Advisory reduced its Boston Scientific (BSX) stake by 57% in Q2 2026, selling an estimated $105K and leaving 1,448 shares worth $61.8K. The position accounts for 0.01% of the portfolio, ranked #569.
Cary Street Partners Investment Advisory first reported a position in BSX in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.62M in Q3 2024. 981 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Cary Street Partners Investment Advisory held 1,448 shares of Boston Scientific worth $61.8K as of Q2 2026.
- Cary Street Partners Investment Advisory sold 1,942 Boston Scientific shares in Q2 2026, an estimated $105K.
- Boston Scientific made up 0.01% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #569 holding.
- Cary Street Partners Investment Advisory first reported a position in Boston Scientific in Q3 2020 and has held it in 18 quarters since.
- Cary Street Partners Investment Advisory's Boston Scientific position peaked at $1.62M in Q3 2024.
- 981 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.